Argus Research analyst John Staszak downgrades McCormick & Co (NYSE:MKC) from Buy to Hold.
Why Clearmind Stock Is Climbing Higher Tuesday
Clearmind Medicine Inc (NYSE: CMND) shares are trading higher Tuesday after the company announced results in its cocaine addiction treatment.